Postoperative efficacy analysis of patients with facial nerve palsy associated with cholesteatoma otitis media: Our experience with 32 patients 1 
| INTRODUCTION
Cholesteatoma, keratinizing stratified squamous epithelium found ectopically within the middle ear, is not an actual tumour. Gradual destruction of the bone is caused by a variety of mechanisms including enzymes, bone erosion, compression caused by oedema, and direct inflammation and infection of the nerve. 1 Facial paralysis is a rare but recognised complication of cholesteatoma. In cases of cholesteatoma associated with facial paralysis, decompression with complete disease eradication is the main therapy.
| ME TH ODS

| Ethical considerations
The study protocol was approved by the Institutional Review Board of the Affiliated Sixth People's Hospital of Shanghai Jiao Tong University.
| Patients
Thirty-two patients diagnosed with facial paralysis associated with cholesteatoma from January 2014 to April 2016 at the Department of ENT Head and Neck Surgery, the Affiliated Sixth People's Hospital, were included in this study. All patients underwent modified mastoidectomy and facial nerve decompression surgery. Among the 22 (68.8%) males and 10 (31.2%) females, 18 (56.2%) participants had lesions on the left side and 14 (43.8%) had them on the right (see Table 1 ). The facial nerve function was evaluated 1 year after the operation according to the House-Brackmann grading system: Grades I and II indicate a favourable prognosis, Grade III indicates an ordinary prognosis and Grades IV, V and VI signify a poor prognosis.
Near-complete decompression ranged from the geniculate ganglion to the stylomastoid foramen. Partial decompression was performed when the extent of the cholesteatoma scope was limited and the degree of facial paralysis was mild, with~3 mm on both ends of the facial nerve exposed after opening of the facial nerve tube. The data were analysed using SPSS software (ver. 20.0; IBM Corp., Armonk, NY, USA). A P value < .05 was considered to indicate statistical significance.
| RESULTS
The 32 patients had different levels of facial nerve canal damage caused by persistent damage of the nerve from cholesteatoma, inflammatory stimulation and ischaemic oedema. In 18 (56.25%) Facial nerve function recovered to Grade II in 100% (20 of 20 cases) of patients who underwent surgery within 4 weeks, and in 50.0% (6 of 12 cases) of patients who underwent surgery after 4 weeks, with a statistically significant difference between them (P = .001; Table 2 ). This suggests that the period of facial paralysis influenced the effects of decompression.
Patients were divided into 2 groups based on the area of facial nerve decompression. Facial nerve function recovered to Grade II in 72.7% (16 of 22 cases) of patients who underwent nearly complete decompression and in 100% (10 of 10 cases) of patients who underwent partial decompression. There were no significant differences between them (P = .073; Table 2 ).
Keypoints
• Patients who underwent surgery within 4 weeks after facial palsy had better outcomes than those who had surgery later.
• The results of partial and near-complete decompression were good, with no difference between the 2 methods.
• Even if the symptom duration of facial paralysis was >4 weeks, surgery still had an impact.
• Unlike in surgery for facial paralysis due to other causes, the integrity of the sheath membrane should be preserved.
• There is a lag in the electroneurography test results. Facial nerve function recovered to Grade II in 87.5% (14 cases) of patients in whom electroneurography showed lighter facial nerve functional damage and in 75% (12 cases) of patients in whom electroneurography showed worse damage, with no significant differences between them (P = .318; Table 2 ).
T A B L E 1 Patient characteristics included in the analysis
| DISCUSSION
We found that the duration of facial paralysis in cholesteatoma was a factor that influenced the recovery outcomes. All of the patients who underwent surgery within 4 weeks of palsy onset had good results, whereas patients operated after 4 weeks showed variable recovery. We also found that the results of partial decompression and near-complete decompression were good, with no difference between the 2 methods.
In traumatic facial paralysis, near-complete decompression is preferred by most surgeons, from the geniculate ganglion to the stylomastoid foramen. Facial nerve decompression not only affects local lesions but also adjacent ones, thereby causing the entire canal to be affected. 2 However, the area of surgical opening of the fallopian canal in cholesteatoma is still a subject of debate. 3 Some recommend near-complete decompression to fully expose it, 4 whereas others prefer a limited canal opening limited that encompasses as small an area as possible. 1, 3 In this study, we found no significant difference between partial decompression and near-complete decompression. The electroneurography test stimulates the foramen stylomastoideum; because of the lag in the extension of a facial nerve injury into the periphery, there is also a lag in the altered response to stimulation.
In conclusion, early surgical treatment is more likely to result in a good prognosis in patients with facial paralysis secondary to cholesteatoma otitis media. Unlike other causes of facial paralysis, the integrity of the sheath membrane should be preserved to prevent the spread of inflammation. Facial nerve recovery was attained by most patients within a year after the operation.
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| MATERIALS AND METHOD
| Ethics
Due to the retrospective nature of this study and anonymisation of data, ethical approval was not required according to the Medical
Research Involving Human Subjects Act in the Netherlands.
| Study design
This is a retrospective case study of subjects receiving a BAHS implant between 1991 and January 2017 in MUMC. A database containing all subjects that have received a BAHS implant was used. Implant length, abutment length, manufacturer and if applicable extrusion or explant surgery are captured in this database.
The database was checked by a second researcher for inconsistencies.
| Statistical analysis
Statistical analyses were performed using R version 3. 
